Amylin Pharmaceuticals (AMLN) dipped in early trade Friday, before settling into a range. The stock has fallen sharply in the last few minutes on increased volume and is now down 2.31 at $18.88.
Amylin Pharmaceuticals is pulling back from the highs of the year and is currently testing the lower end of a 2-week range.
For comments and feedback contact: editorial@rttnews.com
June 05, 2026 16:18 ET A busy week for economic news flow saw a slew of reports being released that reflected the trends in the U.S. labor market. In Europe, economic growth and inflation data gained attention as the European Central Bank and Bank of England head for policy session later in the month. In Asia, the monetary policy session of the Indian central bank was in focus as the country, a major oil importer, reels under the pressures of a weaker rupee and rising inflation.